TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $20,000 | 0.0% | 1,134 | 0.0% | 0.00% | – |
Q2 2019 | $20,000 | -13.0% | 1,134 | 0.0% | 0.00% | – |
Q1 2019 | $23,000 | +21.1% | 1,134 | 0.0% | 0.00% | – |
Q4 2018 | $19,000 | -20.8% | 1,134 | 0.0% | 0.00% | – |
Q3 2018 | $24,000 | 0.0% | 1,134 | 0.0% | 0.00% | – |
Q2 2018 | $24,000 | -14.3% | 1,134 | 0.0% | 0.00% | – |
Q1 2018 | $28,000 | -12.5% | 1,134 | 0.0% | 0.00% | – |
Q4 2017 | $32,000 | +3.2% | 1,134 | 0.0% | 0.00% | – |
Q3 2017 | $31,000 | +6.9% | 1,134 | 0.0% | 0.00% | – |
Q2 2017 | $29,000 | +7.4% | 1,134 | 0.0% | 0.00% | – |
Q1 2017 | $27,000 | +12.5% | 1,134 | 0.0% | 0.00% | – |
Q4 2016 | $24,000 | -11.1% | 1,134 | 0.0% | 0.00% | – |
Q3 2016 | $27,000 | +12.5% | 1,134 | 0.0% | 0.00% | – |
Q2 2016 | $24,000 | -7.7% | 1,134 | 0.0% | 0.00% | – |
Q1 2016 | $26,000 | -7.1% | 1,134 | 0.0% | 0.00% | – |
Q4 2015 | $28,000 | +12.0% | 1,134 | 0.0% | 0.00% | – |
Q3 2015 | $25,000 | -7.4% | 1,134 | 0.0% | 0.00% | – |
Q2 2015 | $27,000 | -3.6% | 1,134 | 0.0% | 0.00% | – |
Q1 2015 | $28,000 | +16.7% | 1,134 | 0.0% | 0.00% | – |
Q4 2014 | $24,000 | -4.0% | 1,134 | 0.0% | 0.00% | – |
Q3 2014 | $25,000 | -3.8% | 1,134 | 0.0% | 0.00% | – |
Q2 2014 | $26,000 | -3.7% | 1,134 | 0.0% | 0.00% | – |
Q1 2014 | $27,000 | +3.8% | 1,134 | 0.0% | 0.00% | – |
Q4 2013 | $26,000 | -3.7% | 1,134 | 0.0% | 0.00% | – |
Q3 2013 | $27,000 | +3.8% | 1,134 | 0.0% | 0.00% | – |
Q2 2013 | $26,000 | – | 1,134 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |